CINDA PHARMA AB has a total of 12 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2017. It filed its patents most often in United Kingdom, Australia and Brazil. Its main competitors in its focus markets pharmaceuticals and biotechnology are RC BIOTECHNOLOGIES INC, LUMOSA THERAPEUTICS CO LTD and EHRENPREIS ELI D.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 3 | |
#2 | Australia | 1 | |
#3 | Brazil | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Israel | 1 | |
#8 | Singapore | 1 | |
#9 | United States | 1 | |
#10 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Orwar Owe | 8 |
#2 | Davidson Max | 8 |
#3 | Max Davidson | 1 |
#4 | Owe Orwar | 1 |
Publication | Filing date | Title |
---|---|---|
SG11202007535VA | Thioredoxin reductase inhibitors for use in the treatment of cancer | |
GB201807415D0 | Cancer treatments | |
GB201802264D0 | Cancer treatments | |
GB201720533D0 | Cancer treatments |